Form 4: ADC Therapeutics Director Peter Hug Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Director Peter Hug sold 1,193 common shares of ADC Therapeutics SA on June 17, 2024, to cover tax withholding obligations related to the vesting and settlement of restricted share units.

Summary

  • On June 17, 2024, Peter Hug, a director of ADC Therapeutics SA, sold 1,193 common shares of the company.
  • The sale was executed at a price of $2.89 per share.
  • The transaction was conducted to cover tax withholding obligations associated with the vesting and settlement of restricted share units.
  • Following the transaction, Peter Hug directly owns 182,644 common shares of ADC Therapeutics SA.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sale of shares to cover taxes) by a company director. It's neutral in nature and doesn't necessarily indicate positive or negative sentiment about the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company directors and executives.

Stakeholder Impact

  • The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the small number of shares involved.

Key Dates

DateDescription
06/17/2024Date of transaction: Peter Hug sold 1,193 common shares.
06/18/2024Date of signature: Lisa Kallebo signed as Attorney-in-Fact for Peter Hug.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.